Neurogenetic Therapies

Neurogenetic Therapies: Advancements in Treating Nervous System Disorders offers a comprehensive resource on the latest gene therapy techniques and their applications in treating neurological disorders. This authoritative guide is designed to provide students, researchers, and clinicians with in-depth knowledge of innovative gene transfer technologies and their clinical implications. The book delves into various gene therapy methods, including genomic DNA-based therapies, vector-mediated delivery, and RNA interference-based gene silencing. It explores the use of these techniques in treating conditions such as Alzheimer's disease, Parkinson's disease, spinal muscular atrophy, and Duchenne muscular dystrophy. Key topics include the molecular and genetic basis of nervous system disorders, the role of epigenetics, and the development of stem cell and genome editing therapies. With contributions from leading experts, the book also addresses regulatory and ethical considerations in gene therapy, providing a balanced perspective on the challenges and opportunities in this rapidly evolving field. Case studies and practical examples illustrate successful gene therapy treatments, offering valuable insights into translating research into clinical practice. This book is an essential resource for students, researchers, and scientists in neurogenetics, neurology, and molecular biology, as well as clinicians interested in the mechanisms and treatment of neurodegenerative diseases. It equips readers with the knowledge and tools needed to advance their work and drive innovation in neurogenetic therapies.

• Provides comprehensive coverage of innovative gene therapy techniques for neurological disorders
• Examines regulatory and ethical considerations in the application of gene therapy
• Explores emerging gene transfer technologies and their clinical applications
• Highlights detailed methodologies and experimental approaches for neurogenetic therapies
• Presents case studies showcasing successful gene therapy treatments for neurodegenerative diseases